Mouhanad El Othmani, MD
Orthopaedic Surgery · Westerly, RINPI 1508399858
Payments from drug & device makers
What this record shows
This record is dominated by education: $14,854 of the $19,611 with a category attached, or 75.7%. Smith+Nephew accounts for 62.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $8,208 and has fallen 90.5% since, to $779 in 2025.
Across 57 payments — averaging $344.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$12K
- Stryker$2K
- Pinnacle, Inc$2K
- Zimmer Biomet$2K
- Linkbio Corp$198
- Johnson & Johnson$198
- plus $252 from 2 others
What the payments were for
- Travel & lodging$1,6638%
- Food & beverage$3,09516%
- Education$14,85476%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 4 | $12,223 |
| Stryker | 27 | $2,470 |
| Pinnacle, Inc | 2 | $2,400 |
| Zimmer Biomet | 14 | $1,870 |
| Linkbio Corp | 2 | $198 |
| Johnson & Johnson | 2 | $198 |
| Medical Device Business Services, Inc. | 5 | $188 |
| Medtronic | 1 | $63 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,611 in reported general payments places this provider in the 75th percentile of 124 orthopaedic surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 536 | $1,823 |
| Omeprazole | 62 | $486 |
| Ondansetron Hcl | 56 | $426 |
| Tramadol Hcl | 102 | $309 |
| Diclofenac Sodium | 29 | $249 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $243 |
| Oxycodone Hcl | 52 | $214 |
| Methylprednisolone | 18 | $167 |
| Cefadroxil | 20 | $124 |
| Amoxicillin | 44 | $45 |
| Prednisone | 28 | $40 |
| Clindamycin Hcl | 13 | $19 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Westerly
- Christopher HutchinsWesterly$75K
- Anthony BuonannoJohnston$2M
- Alan DanielsEast Providence$1.9M
- Robert MarchandWakefield$1.4M
- Michael BradleyWakefield$1.4M
- Edward PaxtonProvidence$244K
- Valentin AntociEast Providence$210K
- Dominic KleinhenzEast Providence$164K
- Bassel DieboEast Providence$138K
- Steven BokshanProvidence$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.